Best for
All-rounder
How to buy ImmuPharma shares | 12p
Own ImmuPharma shares in just a few minutes. Share price changes are updated daily.
ImmuPharma plc (IMM) is a leading biotechnology business based in the UK. It opened the day at 12.2p after a previous close of 12.5p. During the day the price has varied from a low of 12p to a high of 12.95p. The latest price was 12p (25 minute delay). ImmuPharma is listed on the London Stock Exchange (LSE) and employs 17 staff. All prices are listed in pence sterling.
How to buy shares in ImmuPharma
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: IMM in this case.
- Research ImmuPharma shares. The platform should provide the latest information available.
- Buy your ImmuPharma shares. It's that simple.
Best for
Low-cost trading
Best for
US shares
Best for
Beginners
What's in this guide?
- Can I buy shares in ImmuPharma?
- Has coronavirus impacted ImmuPharma shares?
- ImmuPharma shares summary
- Compare share dealing platforms
- Is ImmuPharma stock a buy or sell?
- ImmuPharma performance over time
- ImmuPharma's financials
- How volatile are ImmuPharma shares?
- Does ImmuPharma pay a dividend?
- Other common questions
How has Coronavirus impacted ImmuPharma's share price?
Since the stock market crash in March caused by coronavirus, ImmuPharma's share price has had significant negative movement.
Its last market close was 11.462p, which is 28.36% down on its pre-crash value of 16p and 63.51% up on the lowest point reached during the March crash when the shares fell as low as 7.01p.
If you had bought £1,000 worth of ImmuPharma shares at the start of February 2020, those shares would have been worth £623.98 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth £845.90.
ImmuPharma share price
Use our graph to track the performance of IMM stocks over time.ImmuPharma shares at a glance
Information last updated 2020-12-18.
| Open | 12.2p |
|---|---|
| High | 12.95p |
| Low | 12p |
| Close | 12p |
| Previous close | 12.5p |
| Change | -0.5p |
| Change % | -4% |
| Volume | 1,839,431 |
Information last updated 2020-12-27.
| 52-week range | 7.01p - 18.75p |
|---|---|
| 50-day moving average | 12.414p |
| 200-day moving average | 12.9296p |
| Wall St. target price | 5p |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | -5.1p |
Invest in ImmuPharma shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy ImmuPharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
ImmuPharma price performance over time
Historical closes compared with the last close of 12p
| 1 week (2021-01-12) | -4.57% |
|---|---|
| 1 month (2020-12-18) | 12 |
| 3 months (2020-10-19) | 4.70% |
| 6 months (2020-07-17) | -6.61% |
| 1 year (2020-01-17) | -18.37% |
|---|---|
| 2 years (2019-01-18) | 16.50% |
| 3 years (2018-01-19) | -93.22% |
| 5 years (2016-01-19) | -52.48% |
ImmuPharma financials
| Revenue TTM | £128,395 |
|---|---|
| Gross profit TTM | £77,925 |
| Return on assets TTM | -45.76% |
| Return on equity TTM | -77.71% |
| Profit margin | 0% |
| Book value | 0.034p |
| Market capitalisation | £32.9 million |
TTM: trailing 12 months
ImmuPharma share dividends
We're not expecting ImmuPharma to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
ImmuPharma share price volatility
Over the last 12 months, ImmuPharma's shares have ranged in value from as little as 7.01p up to 18.75p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while ImmuPharma's is 1.3085. This would suggest that ImmuPharma's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
ImmuPharma overview
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity, anti-infectives, metabolism, and cancer. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidate includes IPP-204106, a peptide to modulate angiogenesis with application in cancer and ophthalmology; and BioGlucagon a therapy for low sugar events in diabetes. ImmuPharma plc has a collaboration arrangement with Centre National de la Recherche Scientifique for the development of a peptide technology platform for treating diabetes with glucagon-like peptide -1 agonists, as well as development of peptides as glucagon antagonists to treat type I and type II diabetes; and license and development agreement with Avion Pharmaceuticals LLC. The company was founded in 1999 and is headquartered in London, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy Transportation and Logistics Systems shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares | $50.05
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares | $111.51
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares | $3.745
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy CloudCommerce shares | $0.1275
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares | $0.93
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares | $4.66
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares | 220p
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares | 33.5p
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert